| Ronald Brian Ott, PAC | |
|
10240 Park Meadows Dr, Lone Tree, CO 80124-5425 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Ronald Brian Ott |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 23 Years |
| Location | 10240 Park Meadows Dr, Lone Tree, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700896966 | NPI | - | NPPES |
| 024249 | Other | CO | KAISER COMMERCIAL NUMBER |
| 98987232 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 1499 (Colorado) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | 1499 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Permanente Medical Group Pc | 1254238454 | 1113 |
News Archive
Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle at 30 days, while a procedure that involved use of a catheter to remove the blood clot blocking that coronary artery did not produce these results, according to a study appearing in JAMA.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Obese and overweight Americans who have tried losing weight report far greater overall satisfaction with weight loss surgery and prescription weight loss medications than with diet, exercise and other self-modification methods, an Internet survey finds.
Without congressional intervention, physicians will face a 27.4 percent Medicare pay cut on Jan. 1. This reduction is slightly smaller than the earlier estimate of 29.5 percent.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald Brian Ott, PAC 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Ronald Brian Ott, PAC 10240 Park Meadows Dr, Lone Tree, CO 80124-5425 Ph: (303) 338-4545 |
News Archive
Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle at 30 days, while a procedure that involved use of a catheter to remove the blood clot blocking that coronary artery did not produce these results, according to a study appearing in JAMA.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Obese and overweight Americans who have tried losing weight report far greater overall satisfaction with weight loss surgery and prescription weight loss medications than with diet, exercise and other self-modification methods, an Internet survey finds.
Without congressional intervention, physicians will face a 27.4 percent Medicare pay cut on Jan. 1. This reduction is slightly smaller than the earlier estimate of 29.5 percent.
› Verified 7 days ago